Cargando…

Lectin Complement Pathway Activation is Associated with Massive Proteinuria in PLA2R-Positive Membranous Nephropathy: A Retrospective Study

INTRODUCTION: Complement activation is highly involved in membranous nephropathy. Identifying the mechanism of the complement activation pathway carries crucial therapeutic implications yet remains controversial. This study explored lectin complement pathway activation in PLA2R-associated membranous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiayi, Zhang, Jiao, Wang, Xu, Zheng, Xumin, Gao, Hongmei, Jiang, Shimin, Li, Wenge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195059/ https://www.ncbi.nlm.nih.gov/pubmed/37213477 http://dx.doi.org/10.2147/IJGM.S407073

Ejemplares similares

Activation of Complement Pathways in Kidney Tissue May Mediate Tubulointerstitial Injury in Diabetic Nephropathy
por: Jiang, Shimin, et al.
Publicado: (2022)

Membranous or membranous‐like GN: A case report of massive proteinuria, positive serum with negative PLA2R on biopsy
por: Kaur, Gurwant, et al.
Publicado: (2018)

Complement Deposition Predicts Worsening Kidney Function and Underlines the Clinical Significance of the 2010 Renal Pathology Society Classification of Diabetic Nephropathy
por: Jiang, Shimin, et al.
Publicado: (2022)

Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury
por: Alghadban, Samy, et al.
Publicado: (2019)

Horseshoe kidney with PLA2R-positive membranous nephropathy
por: Shi, Shuai-Shuai, et al.
Publicado: (2021)

Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy
por: Luo, Wentian, et al.
Publicado: (2018)

Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy
por: Geara, Abdallah S., et al.
Publicado: (2021)

Activation of complement C1q and C3 in glomeruli might accelerate the progression of diabetic nephropathy: Evidence from transcriptomic data and renal histopathology
por: Jiao, Yuanyuan, et al.
Publicado: (2022)

Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2019)

Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
por: Chen, Ruiying, et al.
Publicado: (2022)

Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria
por: He, Peng, et al.
Publicado: (2021)

Successful treatment of PLA(2)R1-antibody positive membranous nephropathy with ocrelizumab
por: Schmidt, Tilman, et al.
Publicado: (2020)

Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Correction to: Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy
por: Shang, Shunlai, et al.
Publicado: (2022)

PLA(2)R Antibody Levels and Clinical Outcome in Patients with Membranous Nephropathy and Non-Nephrotic Range Proteinuria under Treatment with Inhibitors of the Renin-Angiotensin System
por: Hoxha, Elion, et al.
Publicado: (2014)

Correction: The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Risk factors of venous thromboembolism in anti-PLA2R-positive and negative primary membranous nephropathy
por: Wu, Henry H L, et al.
Publicado: (2022)

Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function
por: Tan, Min, et al.
Publicado: (2019)

Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
por: Baker, Lyle W., et al.
Publicado: (2021)

Anti-PLA(2)R Antibodies in Chinese Patients with Membranous Nephropathy
por: Li, Xin, et al.
Publicado: (2016)

Membranous nephropathy PLA2R+ associated with Chagas disease
por: Xavier-Júnior, José Cândido Caldeira, et al.
Publicado: (2015)

The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
por: Dahan, Karine, et al.
Publicado: (2017)

Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: A cross-sectional study
por: Pang, Lu, et al.
Publicado: (2017)

Factors associated with the progression of mesangial lesions in IgA nephropathy: A comparative analysis of renal re-biopsies
por: Li, Yetong, et al.
Publicado: (2022)

PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy
por: Ge, Yong-Chun, et al.
Publicado: (2016)

Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria
por: Sun, Jing, et al.
Publicado: (2023)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
por: Zheng, Shirong, et al.
Publicado: (2016)

Response to immunosuppressive therapy in PLA(2)R- associated and non-PLA(2)R- associated idiopathic membranous nephropathy: a retrospective, multicenter cohort study
por: Wang, Jia, et al.
Publicado: (2017)

Utility of non-HDL-C in predicting proteinuria remission of idiopathic membranous nephropathy: a retrospective cohort study
por: Dong, Lei, et al.
Publicado: (2021)

Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy
por: Berchtold, Lena, et al.
Publicado: (2017)

A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy
por: Wanderley, David Campos, et al.
Publicado: (2019)

Rare Occurrence of PLA2R-Positive Membranous Nephropathy in a Patient with Sjogren's Syndrome and CIDP
por: Gupta, Nimish, et al.
Publicado: (2020)

A Case of Pla2r and Exostosin 1 Positive Membranous Nephropathy - The Diagnostic and Therapeutic Dilemma
por: Sivagnanam, Harish, et al.
Publicado: (2023)

Rapamycin Ameliorates Proteinuria and Restores Nephrin and Podocin Expression in Experimental Membranous Nephropathy
por: Stratakis, Stavros, et al.
Publicado: (2013)

The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: Du, Yu, et al.
Publicado: (2014)

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

Concurrent PLA2R-Associated Membranous Nephropathy and Antiglomerular Basement Membrane Disease
por: Jagannathan, Geetha, et al.
Publicado: (2022)

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial
por: Brglez, Vesna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_97au96hnu75ssf3238ng4s4t2v